FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 1951 - Advisory Committee on Research on Women's Health - Statutory (Congress Created)

GENERAL INFORMATION

Committee Name	Advisory Committee on Research on Women's Health	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	1951
Original Establishment Date	10/3/1994	Committee Status	Chartered
Actual Termination Date		Committee URL	https://orwh.od.nih.gov/about/advisory-committe...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	18
Terminated This FY	No	Designated Fed Officer Position Title*	HEALTH SCIENCE ADMINISTRATOR
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	9/29/2024	Designated Federal Officer First Name*	LUCIA
Date Of Renewal Charter	9/29/2026	Designated Federal Officer Middle Name
Projected Termination Date		Designated Federal Officer Last Name*	HINDORFF
Exempt From Renewal*	No	Designated Federal Officer Suffix
Specific Termination Authority		Designated Federal Officer Phone*	240-271-1509
Establishment Authority*	Statutory (Congress Created)	Designated Federal Officer Fax*
Specific Establishment Authority*	42USC287d(d)	Designated Federal Officer Email*	otawangv@nih.gov
Effective Date Of Authority*	12/9/1998
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Scientific Technical Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	Not Applicable
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	In accordance with the NIH Revitalization Act of 1993, members of the Committee provide leadership by reviewing the proposed priorities of the Office of Research on Women’s Health (ORWH), research and career development programs, Conferences, Outreach and Inclusion activities on an annual basis. Committee discussions in FY25 included updates on ORWH activities and priorities; an update from the Acting Director of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) on DPCPSI Vision and Priorities; an update from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Director, National Library of Medicine (NLM) Deputy Director, and NIH Small Business Education and Entrepreneurial Development (SEED) Office Director on their roles in supporting women’s health research; a special update from the National Academies of Sciences, Engineering, and Medicine (NASEM); panel presentations on Data Science and Technology, Engineering, and Innovation in Women’s Health Research; and concept clearances for two ORWH programs. Lastly, members of the Committee also reviewed and commented on selected content of the FY24 – FY25 NIH Biennial Report.
How is membership balanced?*	The Committee will consist of no fewer than 12, and not more than 18 members, appointed by the Director, NIH, who are not officers or employees of the Federal Government, from among physicians, practitioners, scientists and other health professionals, whose clinical practice, research specialization, or professional expertise include a significant focus on research and the health of women. A majority of the appointed members will be women. Members have research interests and responsibilities paralleling those of the Office of Research on Women's Health.
How frequent & relevant are cmte mtgs?*	In accordance with the NIH Revitalization Act of 1993, the Advisory Committee on Research on Women’s Health (ACRWH) meets no less than one time within a fiscal year and the dates are set well in advance to ensure maximum participation. In FY2025, the Committee met three times: October 8 and December 9, 2024, and June 17, 2025. This legislation also established the governing structure of the ACRWH in providing external input on how to improve and prioritize research that addresses women’s health to NIH. During those meetings, the Committee voted on concept clearances for two ORWH programs.
Why advice can't be obtained elsewhere?*	The quality, scope, and balance of advice from this Committee cannot be obtained from NIH staff or from other established sources because the membership of the Committee is constituted to meet the specific requirements of the mandated mission of the Committee by the NIH Revitalization Act of 1993. The ACRWH is composed of both scientific and public members who provide in-depth knowledge on topics focused on research on the health of women, sex as a biological variable, and public opinions combined with a strong background in the history of women’s health research at NIH.
Why close or partially close meetings?	N/A
Recommendation Remarks	Members Rotating Off/On-Boarding: Three members rotated-off (Drs. Templeton, Jagsi, Simon). Members: The terms for Drs. Aninye and Anderson changed due to administrative extensions though 1/26/2026. As such, their term of service end dates are different than what was reported on the FY24 ACR. Reports: This committee did not produce any public reports this fiscal year.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	No
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	No	Action Other	Yes
Outcome Increased Customer Satisfaction	No	Action Comment	The committee makes recommendations to Federal staff regarding research priorities, inclusion of women in clinical trials, and opportunities for women in biomedical careers.
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment		Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	NIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.	Grants Review Comment	N/A
Number Of Recommendations*	77	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	The Committee makes broad suggestions or individual recommendations on research priorities conducted or supported by the NIH with respect to research on the health of women. ACRWH meetings are designed to solicit the Committee’s feedback on the highest priority topics on which ORWH is seeking input. The Committee may also comment broadly on ORWH activities, including the development of methodologies to understand the circumstances in which obtaining data specific to women is an appropriate function for clinical trials of treatments and therapies and to understand priorities in carrying out this research. The Committee may also provide recommendations regarding the inclusion of women in clinical trials and opportunities for women’s health researchers in biomedical careers.	Access Agency Website	Yes
% of Recs Fully Implemented*	0.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	Due to the complexity of the recommendations made by this committee on policy and program areas, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	Due to the complexity of the issues and the role of this committee, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.	Access Other	No
Agency Feedback*	Yes	Access Comment	N/A
Agency Feedback Comment*	Information is provided to the public at each meeting. The public can view information related to the Committee through the committee’s official website.	Narrative Description*	The National Institutes of Health (NIH), Advisory Committee on Research on Women’s Health (ACRWH) is a congressionally mandated committee (NIH Revitalization Act of 1993, P.L. 103-43) and required by 42 U.S.C. 287d(d), section 486(d) of the Public Health Service (PHS) Act, as amended that plays a critical role in providing expert level input to the Office of Research on Women’s Health on how to best address gaps in knowledge about women’s health through research as well as crucial insights on priorities for accelerating advances to improve the health of women and women in science careers. On an annual basis, members of the Committee provide advice on all of the above by reviewing and contributing to the Office of Research on Women’s Health (ORWH) proposed research priorities; research and career development programs; conferences; and outreach and inclusion activities. NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. NIH works toward that mission by: conducting research in its own laboratories; supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad; helping in the training of research investigators; and fostering communication of medical and health sciences information. Section 492 of the PHS Act states that The Secretary...shall by regulation require appropriate technical and scientific peer review of - (A) applications...; and (B) biomedical and behavioral research and development contracts...

COSTS

1. Payments to Non-Federal Members*	$5,800.00	1. Est Paymnts to Non-Fed Membrs Nxt FY*	$5,800.00
2. Payments to Federal Members*	$2,244.00	2. Est. Payments to Fed Members Next FY*	$2,244.00
3. Payments to Federal Staff*	$48,220.00	3. Estimated Payments to Federal Staff*	$50,761.00
4. Payments to Consultants*	$600.00	4. Est. Payments to Consultants Next FY*	$600.00
5. Travel Reimb. For Non-Federal Membrs*	$8,426.00	5. Est Travel Reimb Non-Fed Membr nxtFY*	$8,473.00
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*	$3,977.00	8. Est Travel Reimb to Consltnts Nxt FY*	$3,998.00
10. Other Costs	$147,896.00	10. Est. Other Costs Next FY*	$149,376.00
11. Total Costs	$217,163.00	11. Est. Total Next FY*	$221,252.00
Date Cost Last Modified	9/17/2025 12:55 PM	Est. Fed Staff Support Next FY*	0.20
Federal Staff Support (FTE)*	0.20	Est Cost Remarks	Daily salary costs have been estimated for Federal and/or Ex Officio members of this committee. The dollar figure represents a portion of their annual salary. No funds have been transferred between the committee and the agency. No additional funds are paid to Federal employee due to membership on this committee.
Cost Remarks	Daily salary costs have been estimated for Federal and/or Ex Officio members of this committee. The dollar figure represents a portion of their annual salary. No funds have been transferred between the committee and the agency. No additional funds are paid to Federal employee due to membership on this committee.

Interest Areas

Category Area Medicine Health and Health Research Research Research and Development

Custom Links

Committee Level Reports